Aquacel Ribbon
DeviceSubjects who received an Aquacel WSF Ribbon
NCT Number: NCT07308665
Retrospective, multi-site, non-comparative, post-market study
Looking for future studies?
Notify MeAll sexes
Observational
Retrospective, multi-site, non-comparative, post-market study to evaluate real-world performance of Aquacel WSF Ribbon dressings in wound healing
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects who received an Aquacel WSF Ribbon
Time frame: Baseline and week 4, 12, 20
Time to complete wound closure, defined as 100% epithelialization of the wound surface
Time frame: Baseline and week 4, 12, 20
Measured size (area, volume) of target wound at each visit
Time frame: Baseline and week 4, 12, 20
Measured wound depth at each visit
Time frame: Baseline and week 4, 12, 20
Changes in exudate volume
Time frame: Up to week 20
Number of Aquacel WSF Ribbon applications per subject over treatment course
Time frame: Up to week 20
Number of visit frequency
Time frame: Baseline and week 4, 12, 20
Aquacel WSF Ribbon wear time
ConvaTec Inc.
Industry
A Multi-site Retrospective Study of the Real-world Performance of Aquacel With Strengthening Fiber (WSF) Ribbon Dressings
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05101473
Cardiovascular Diseases, Diabetes Complications
Køge, Denmark
View Trial DetailsNCT03985306
Cardiovascular Diseases, Diabetes Complications
Herlev, Denmark
View Trial DetailsNCT05251480
Cardiovascular Diseases, Diabetes Complications
Emo, Ontario, Canada
View Trial DetailsNCT07418073
Cardiovascular Diseases, Diabetes Complications
Ljubljana, Slovenia
View Trial Details